DeniseALevitanMD

PubMed

• 73 citations
  A Phase I Study of the First-in-Class Antimitochondrial Metabolism Agent, CPI-613, in Patients with Advanced Hematologic Malignancies
  Timothy S. Pardee, King Chung Lee, John Luddy, Claudia Maturo, Robert J. Rodriguez, Scott Isom, Lance D. Miller, Kristin Stadelman, Denise Levitan, David D. Hurd, Lesl...> ;Clinical Cancer Research. 2014 Oct 15
• 29 citations
  Arsenic Trioxide During Consolidation for Patients with Previously Untreated Low/Intermediate Risk Acute Promyelocytic Leukaemia May Eliminate the Need for Maintenance...
  Steven Coutre, Megan Othus, Bayard L. Powell, Cheryl L. Willman, Wendy Stock, Elisabeth Paietta, Denise Levitan, Meir Wetzler, Eyal C. Attar, Jessica K. Altman, Steven...> ;British Journal of Haematology. 2014 May 1
• 834 citations
  Lenalidomide after stem-cell transplantation for multiple myeloma
  , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;The New England Journal of Medicine. 2012 May 9
• 99 citations
  The Feasibility of Inpatient Geriatric Assessment for Older Adults Receiving Induction Chemotherapy for Acute Myelogenous Leukemia
  Heidi D. Klepin, Ann M. Geiger, Janet A. Tooze, Stephen B. Kritchevsky, Jeff D. Williamson, Leslie R. Ellis, Denise Levitan, Timothy S. Pardee, Scott Isom, Bayard L. P...> ;Journal of the American Geriatrics Society. 2011 Oct 1
• Two case reports of MDS with chromosome 7 abnormalities after treatment of AIDS-related Burkitt lymphoma occurring in patients on HAART therapy.
  Levitan DA, Lyerly S, Sweet M, Manuel M, Berenzon DP, Pardee TS, Ellis LR, Powell BL> ;J. Clin. Oncol.. 2011-05-20
• Altered mitochondrial metabolism as a target in acute myeloid leukemia.
  Pardee TS, Levitan DA, Hurd DD> ;J. Clin. Oncol.. 2011-05-20
• 8 citations
  Six patients with early-stage cutaneous T-cell lymphoma successfully treated with topical 5-fluorouracil.
  Ajith P. Kannangara, Denise Levitan, Alan B. Fleischer> ;Journal of Drugs in Dermatology. 2010 Aug 1
• 5 citations
  Possible Role of Engraftment Syndrome and Autologous Graft-Versus-Host Disease in Myelodysplastic Syndrome After Autologous Stem Cell Transplantations: Retrospective A...
  Yi-Kong Keung, Michael W. Beaty, Mark J. Pettenati, Denise Levitan, David D. Hurd> ;Clinical Lymphoma, Myeloma & Leukemia. 2010 Apr 1
• Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma?
  Keung Yk, Denise Levitan, Kenneth Zamkoff, David D. Hurd> ;Bone Marrow Transplantation. 2010 Feb 1
• 18 citations
  Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
  Ajith P. Kannangara, Denise Levitan, Alan B. Fleischer> ;The Journal of Dermatological Treatment. 2009 Oct 28
• 73 citations
  EAF1, a novel ELL-associated factor that is delocalized by expression of the MLL-ELL fusion protein.
  Federico Simone, Paul E. Polak, Joseph J. Kaberlein, Roger T. Luo, Denise A. Levitan, Michael J. Thirman> ;Blood. 2001 Jul 1
• 5 citations
  Peripheral blood mononuclear cell dihydropyrimidine dehydrogenase activity in volunteers with and without diabetes mellitus
  Gini F. Fleming, Everett E. Vokes, John B. Buse, Rosemarie Mick, Jody Dushay, Denise A. Levitan, M. Eileen Dolan> ;Cancer Chemotherapy and Pharmacology. 1996 Jan 1
• 179 citations
  Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukemia.
  Michael J. Thirman, Denise A. Levitan, Hirofumi Kobayashi, M C Simon, Janet Rowley> ;Proceedings of the National Academy of Sciences of the United States of America. 1994 Dec 6
• Join now to see all